AMN Healthcare (NYSE: AMN) plans J.P. Morgan Healthcare Conference talk

Rhea-AI Filing Summary

AMN Healthcare Services, Inc. will present at the J.P. Morgan Healthcare Conference on January 14, 2026. The company has prepared a slide presentation for this event, which is attached as Exhibit 99.1 and will also be available through the Investor Relations section of its website at https://ir.amnhealthcare.com/.

The information related to this conference appearance is being furnished under Item 7.01 and is not deemed filed under securities laws, meaning it will only be incorporated into other documents by specific reference. The report is signed on behalf of the company by Chief Executive Officer Cary Grace.

8-K Event Classification

2 items: 7.01, 9.01

2 items

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, and exhibit attachments filed with this report.

Understanding 8-K Material Events →

0001142750false00011427502026-01-142026-01-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

____________________

FORM 8-K

_____________________

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): January 14, 2026

AMN HEALTHCARE SERVICES, INC.

(Exact Name of Registrant as Specified in Charter)

Delaware			001-16753			06-1500476
(State or Other Jurisdiction of Incorporation)			(Commission File Number)			(I.R.S. Employer Identification No.)

2999 Olympus Boulevard, Suite 300

Dallas, Texas 75019

(Address of Principal Executive Offices)

Registrant’s telephone number, including area code: (866) 871-8519

NOT APPLICABLE
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR240.14d-2(b))

☐ Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol			Name of each exchange on which registered
Common Stock, par value $0.01 per share			AMN			NYSE

☐			Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2). Emerging growth company
☐			If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Item 7.01. Regulation FD

The management of AMN Healthcare Services, Inc. (the “Company”) will present at the J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026. A slide presentation of materials to be presented at the conference is attached hereto as Exhibit 99.1 and will also be accessible via the Investor Relations section of the Company’s website: https://ir.amnhealthcare.com/.

The information in this Form 8-K is being furnished, not filed, pursuant to Item 7.01. Accordingly, the information will not be incorporated by reference into any document filed by AMN Healthcare Services, Inc. under the Securities Act of 1933, as amended, except as set forth by specific reference in such filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

99.1 Investor Presentation - January 2026

104     Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMN Healthcare Services, Inc.

Date: January 14, 2026			By:			/s/ Cary Grace
			Name:			Cary Grace
			Title:			Chief Executive Officer

FAQ

What event is AMN (AMN) participating in according to this report?

AMN Healthcare Services, Inc. will present at the J.P. Morgan Healthcare Conference on January 14, 2026.

Where can investors find AMN (AMN)'s J.P. Morgan conference presentation slides?

The slide presentation is attached as Exhibit 99.1 and will be accessible via the Investor Relations section of AMN Healthcare’s website at https://ir.amnhealthcare.com/.

How is the conference information for AMN (AMN) being treated under securities rules?

The conference information is being furnished, not filed, under Item 7.01, and will only be incorporated into other documents by specific reference.

Who signed this AMN (AMN) current report?

The report was signed on behalf of AMN Healthcare Services, Inc. by Cary Grace, the company’s Chief Executive Officer.

What exhibit types are included with this AMN (AMN) report?

The report includes Exhibit 99.1, the slide presentation for the J.P. Morgan Healthcare Conference, and Exhibit 104, the cover page interactive data file embedded within the Inline XBRL document.